Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

VYNE Therapeutics (VYNE) Inventory Average (2020 - 2021)

VYNE Therapeutics (VYNE) has disclosed Inventory Average for 2 consecutive years, with $7.7 million as the latest value for Q4 2021.

  • For the quarter ending Q4 2021, Inventory Average rose 9.3% year-over-year to $7.7 million, compared with a TTM value of $7.7 million through Dec 2021, up 9.3%, and an annual FY2021 reading of $7.3 million, up 67.75% over the prior year.
  • Inventory Average was $7.7 million for Q4 2021 at VYNE Therapeutics, down from $8.2 million in the prior quarter.
  • Across five years, Inventory Average topped out at $8.2 million in Q2 2021 and bottomed at $2.3 million in Q1 2020.